Influence of angiotensin-converting enzyme inhibitor ramipril on indicators of tubular kidney lesion in patients with chronic glomerulonephritis

1. Coppo R, Cattran D. The new oxford clinic-pathological classification of IgA nephropathy. Sec Biol Med Sci. 2010;1:241-8.Search in Google Scholar

2. Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv Chronic Kidney Dis. 2010;17:469-79.10.1053/j.ackd.2010.09.002Search in Google Scholar

3. Presta P, Minutolo R. Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10-year follow-up. Eur J Intern Med. 2011;22:90-4.10.1016/j.ejim.2011.08.021Search in Google Scholar

4. Wright JT, Bakris G, Greene Т. African American study of kidney disease and hypertension study group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2013;288:2421-31.10.1001/jama.288.19.2421Search in Google Scholar

5. López-Novoa J, Rodríguez-Peña A, Ortiz A, Martínez-Salgado C, López Hernández F. Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. Nephrology (Saint-Petersburg). 2013;17(2):9-38.Search in Google Scholar

6. Okon K, Sulowicz W, Smolenski O. Interstitial, tubular and vascular factors in progression of rimary glomerulonephritis. Pol J Pathol. 2017;58(2):73-8.Search in Google Scholar

7. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens. 2018;43(22):113-27.Search in Google Scholar

8. Schmidt-Ott KM. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury – where do we stand today? Nephrol Dial Transplant. 2011;26(3):762-4.10.1093/ndt/gfr006Search in Google Scholar

9. Ding H, He Y, Li K, Yang J, Li X, Lu, et al. Urinary neutrophil gelatinase-associated lipocalin is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2017; 42:227-34.Search in Google Scholar

10. Bolignano D, Coppolino G, Campo S. Urinary neutrophil gelatinase-associated lipocalin is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant. 2008;23:414-6.10.1093/ndt/gfm541Search in Google Scholar

11. Bolignano D, Lacquaniti A, Coppolino G. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):44-237.10.2215/CJN.03530708Search in Google Scholar

12. Huang F, Horikoshi S, Kurusu A. Urinary levels of interleukin-18 and disease activity in patients with IgA nephropathy. J Clin Lab Anal. 2011;15(1):30-4.10.1002/1098-2825(2001)15:1<30::AID-JCLA6>3.0.CO;2-XSearch in Google Scholar

13. Beili S, Ni Z, Cao L, Zhou M. Serum IL-18 Is closely associated with renal tubulointerstitial injury and predicts renal prognosis in IgA Nephropathy. Mediators Inflamm. 2012;2:1-9.Search in Google Scholar

14. Shimizu C, Fuijta T, Fuke Y, Ito K, Satomura A, Matsomuto K, Soma M. High circulating levels of the Interleukin-18 binding protein indicate the severity of glomerular involvement in systemic lupus erythematosus. Mod Rheumatol. 2012;22(1):73-9.10.3109/s10165-011-0471-2Search in Google Scholar